Ani pharmaceuticals announces fda approval and imminent launch of dexamethasone tablets usp

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced that the company received u.s. food and drug administration (fda) approval for the abbreviated new drug application (anda) for dexamethasone tablets usp 1.5mg, 4mg and 6mg. ani's dexamethasone tablets usp 1.5mg, 4mg and 6mg are the generic version of the reference listed drug (rld) decadron®. the current annual u.s. market for dexamethasone tablets usp 1.5mg, 4mg and 6mg is approximat
ANIP Ratings Summary
ANIP Quant Ranking